Using Ibrutinib in Earlier Lines of Treatment Results in Better Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Paul M. Barr, Susan O’Brien, Sandra Dai et al.|Blood|2019

Cited by 2